Differentiation-related mechanisms which suppress DNA replication

Experimental Cell Research

Volumn 248, Issue 1, 1999, Pages 58-73

  Coffman, Frederick D ^a   Studzinski, George P ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P21; PROTEIN P27; PROTEIN P53; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA REPAIR; DNA REPLICATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SHORT SURVEY;

ANIMALIA; MAMMALIA;

EID: 0033541418     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4457     Document Type: Article

References (166)

1. Studzinski G. P., Harrison L. E. Differentiation-related changes in the cell cycle traverse. Int. Rev. Cytol. 189:1999.
2. Kockx M., McCabe L., Stein J. L., Lian J. B., Stein G. S. Influence of DNA replication inhibition on expression of cell growth and tissue-specific genes in osteoblasts and osteosarcoma cells. J. Cell. Biochem. 54:1994;47-55.
3. Spriggs L. L., Hill S. M., Jeter J. R. Jr. Proliferation is required for induction of terminal differentiation of Friend erythroleukemia cells. Biochem. Cell Biol. 70:1992;555-564.
4. Dimri G. P., Testori A., Acosta A., Campisi J. Replicative senescence, aging and growth-regulatory transcription factors. Biol. Signals. 5:1996;154-162.
5. Ruoslahti E. Stretching is good for a cell. Science. 276:1997;1345-1346.
6. Huang S., Chen C. S., Ingber D. E. Control of cyclin D1, p27KIP1, and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension. Mol. Biol. Cell. 9:1998;3179-3193.
7. Masur S. K., Dewal H. S., Dinh T. T., Ehrenburg I., Petridou S. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc. Natl. Acad. Sci. USA. 93:1996;4219-4223.
8. Soddu S., Blandino G., Scardigi R., Martinelli R., Rizzo M. G., Crescenzi M., Sacchi A. Wildtype p53 induces diverse effects in 32D cells expressing different oncogenes. Mol. Cell. Biol. 16:1996;487-495.
9. Elledge S. J. Cell cycle checkpoints: Preventing an identity crisis. Science. 274:1996;1664-1672.
10. Sherr C. J. Cancer cell cycles. Science. 274:1996;1672-1677.
11. 1. Adv. Cancer Res. 74:1998;1-24.
12. 1. Prog. Cell Cycle Res. 2:1996;15-27.
13. Naysmyth K. Putting the cell cycle in order. Science. 274:1996;1643-1645.
14. Morgan D. O. Principles of cdk regulation. Nature. 374:1995;131-134.
15. Ball K. L. p21: Structure and functions associated with cyclin-CDK binding. Prog. Cell Cycle Res. 3:1997;125-134.
16. Hengst L., Reed S. I. Inhibitors of the Cip/Kip family. Curr, Top. Microbiol. Immunol. 227:1998;25-41.
17. Townsley F., Ruderman J. V. Trends Cell Biol. 8:1998;238-244.
18. 13. Cancer Res. 56:1996;264-267.
19. 13. Cancer Res. 57:1997;2851-2855.
20. Bastians H., Townsley F. M., Ruderman J. V. The cyclin-dependent kinase inhibitor p27Kip1 induces N-terminal proteolytic cleavage of cyclin A. Proc. Natl. Acad. Sci. USA. 95:1998;15374-15381.
21. Hua X. H., Yan H., Newport J. A role for Cdk2 kinase in negatively regulating DNA replication during S phase of the cell cycle. J. Cell Biol. 137:1997;183-192.
22. Rowles A., Blow J. J. Chromatin proteins involved in the initiation of DNA replication. Curr. Opin. Genet. Dev.t. 7:1997;152-157.
23. Donovan S., Diffley J. F. Replication origins in eukaryotes. Curr. Opin. Genet. Devel. 6:1996;203-207.
24. Hatakeyama M., Weinberg R. A. The role of RB in cell cycle control. Prog. Cell Cycle Res. 1:1995;9-19.
25. DePinho R. A. The cancer-chromatin connection. Nature. 391:1998;533-536.
26. Juan G., Li X., Darzynkiewicz Z. Phosphorylation of retinoblastoma protein assayed in individual HL-60 cells during their proliferation and differentiation. Exp. Cell Res. 244:1998;83-92.
27. 1. Proc. Natl. Acad. Sci. USA. 93:1996;11516-11521.
28. Van Wijnen A. J., Cooper C., Odgren P., Aziz F., DeLuca A., Shakoori R. A., Giordano A., Quesenberry P. J., Lian J. B., Stein G. S., Stein J. L. Cell cycle-dependent modifications in activities of pRb-related tumor suppressors and proliferation-specific CDP/cut homeodomain factors in murine hematopoietic progenitor cells. J. Cell. Biochem. 66:1997;512-523.
29. Aziz F., Van Wijnen A., Vaughan P. S., Wu S., Shakoori R. A., Lian J. B., Soprano K. J., Stein J. L., Stein G. S. The integrated activities of IRF-2 (HiNF-M), CDP/cut (HiNF-D) and H4TF-2 (HiNF-P) regulate transcription of a cell cycle controlled human histone H4 gene: Mechanistic difference between distinct H4 genes. Mol. Biol. Rep. 25:1998;1-12.
30. Adnane, J. Shao, Z. Robbins, P. D. Cyclin D1 associates with the TBP-associated factor TAF(II)250 to regulate Sp1-mediated transcription, Oncogene, 18, 239, 247.
31. Leggett R. W., Armstrong S. A., Barry D., Mueller C. R. Sp1 is phosphorylated and its DNA binding activity down-regulated upon terminal differentiation. J. Biol. Chem. 270:1995;25879-25884.
32. Rao J., Zhang F., Donnelly R. J., Spector N. L., Studzinski G. P. Truncation of Sp1 transcription factor by myeloblastin in undifferentiated HL60 cells. J. Cell. Physiol. 175:1998;121-128.
33. Harrington E. A., Bruce J. L., Harlow E., Dyson N. pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc. Natl. Acad. Sci. USA. 95:1998;11945-11950.
34. Loeb L. A. Cancer cells exhibit a mutator phenotype. Adv. Cancer Res. 72:1998;25-56.
35. Usmani B. A. Genomic instability and metastatic progression. Pathobiology. 61:1993;109-116.
36. 01. Mol. Cell. Biochem. 16:1996;6965-6976.
37. Giaccia A. J., Kastan M. B. The complexity of p53 modulation: Emerging patterns from divergent signals. Genes Dev. 12:1998;2973-2983.
38. Prives C. Signaling to p53: Breaking the MDM2-p53 circuit. Cell. 95:1998;5-8.
39. el-Deiry W. S. p21/p53, cellular growth control and genomic integrity. Curr. Top. Microbiol. Immunol. 227:1998;121-137.
40. Soddu S., Blandino G., Citro G., Scardigli R., Piaggio G., Ferber A., Calabretta B., Sacchi A. Wild-type p53 gene expression induces granulocytic differentiation of HL60 cells. Blood. 15:1994;2230-2237.
41. Rizzo M. G., Zepparoni A., Cristofanelli B., Scardigli R., Crescenzi M., Blandino G., Giuliacci S., Ferrari S., Soddu S., Sacchi A. Wt-p53 action in human leukaemia cell lines corresponding to different stages of differentiation. Br. J. Cancer. 77:1998;1429-1438.
42. Lang D., Miknyoczki S. J., Huang L., Ruggeri B. A. Stable reintroduction of wild-type p53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells. Oncogene. 16:1998;1593-1602.
43. Ehinger M., Bergh G., Johnsson E., Baldetorp B., Olsson I., Gullberg U. p53-dependent and -independent differentiation of leukemic U-937 cells: relationship to cell cycle control. Exp. Hematol. 26:1998;1043-1052.
44. Ehinger M., Bergh G., Johnsson E., Gullberg U., Olsson I. The tumor suppressor gene p53 can mediate transforming growth factor beta1-induced differentiation of leukemic cells independently of activation of the retinoblastoma protein. Cell Growth Differ. 8:1997;1127-1137.
45. Casamassimi A., Miano M. G., Porcellini A., De Vita G., de Nigris F., Zannini M., Di Lauro R., Russo T., Avvedimento V. E., Fusco A. p53 genes mutated in the DNA binding site or at a specific COOH-terminal site exert divergent effects on thyroid cell growth and differentiation. Cancer Res. 58:1998;2888-2894.
46. Li Z. R., Hromchak R., Mudipalli A., Bloch A. Tumor suppressor proteins as regulators of cell differentiation. Cancer Res. 58:1998;4282-4287.
47. Tamir Y., Bengal E. p53 protein is activated during muscle differentiation and participates with MyoD in the transcription of muscle creatine kinase gene. Oncogene. 17:1998;347-356.
48. Song X., Sheppard H. M., Norman A. W., Liu X. Mitogen-activated protein kinase is involved in the degradation of p53 protein in the bryostatin-1-induced differentiation of the acute promyelocytic leukemia NB4 cell line. J. Biol. Chem. 274:1999;1677-1682.
49. Scardigli R., Bossi G., Blandino G., Crescenzi M., Soddu S., Sacchi A. Expression of exogenous wt-p53 does not affect normal hematopoiesis: implications for bone marrow purging. Gene Ther. 4:1997;1371-1378.
50. Sherman L., Jackman A., Itzhaki H., Stoppler M. C., Koval D., Schlegel R. Inhibition of serum- and calcium-induced differentiation of human keratinocytes by HPV16 E6 oncoprotein: role of p53 inactivation. Virology. 237:1997;296-306.
51. 3. Cancer Lett. 129:1998;61-68.
52. van Oijen M. G., Tilanus M. G., Medema R. H.m, Slootweg P. J. Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J. Oral Pathol. Med. 27:1998;367-375.
53. Rey M. J., Fernandez P. L., Jares P., Munoz M., Nadal A., Peiro N., Nayach I., Mallofre C., Muntane J., Campo E., Estape J., Cardesa A. p21WAF1/Cip1 is associated with cyclin D1CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma. J. Pathol. 184:1998;265-271.
54. Riccioni T., Cirielli C., Wang X., Passaniti A., Capogrossi M. C. Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiationin vitroin vivo. Gene Ther. 5:1998;747-754.
55. Ferreira A., Kosik K. S. Accelerated neuronal differentiation induced by p53 suppression. J. Cell Sci. 109:1996;1509-1516.
56. Bellido T., O'Brien C. A., Roberson P. K., Manolagas S. C. Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J. Biol. Chem. 273:1998;21137-21144.
57. 1. J. Biol. Chem. 273:1998;13713-13718.
58. Sidi Y., Hudson J. L., Mitchell B. S. Effects of guanine ribonucleotide accumulation on the metabolism and cell cycle of human lymphoid cells. Cancer Res. 45:1985;4940-4945.
59. Chen Y., Sokoloski J. A., Chu E., Sartorelli A. C. Regulation of the expression of enzymes involved in the replication of DNA in chemically induced monocytic/macrophagic differentiation of HL-60 leukemia cells. Leuk. Res. 22:1998;697-703.
60. Chen Y., Sokoloski J. A., Chu E., Sartorelli A. C. Regulation of the expression of enzymes involved in the replication of DNA in chemically induced granulocytic differentiation of HL-60 leukemia cells. Leuk. Res. 22:1998;687-695.
61. Mueller G. C., Kajiwara K. Early- and late-replicating deoxyribonucleic acid complexes in HeLa nuclei. Biochim. Biophys. Acta. 114:1965;108-115.
62. Widrow R. J., Hansen R. S., Kawame H., Gartler S. M., Laird C. D. Very late DNA replication in the human cell cycle. Proc. Natl. Acad. Sci. USA. 95:1998;11246-11250.
63. Vassilev L. T., DePamphilis M. L. Guide to identification of origins of DNA replication in eukaryotic cell chromosomes. Crit. Rev. Biochem. Mol. Biol. 27:1992;445-472.
64. Huberman J. A., Spotila L. D., Nawotka K. A., El-Assouli S. M., Davis L. R. Thein vivo. Cell. 51:1987;473-481.
65. Fangman W. L., Brewer B. J. Activation of replication origins within yeast chromosomes. Annu. Rev. Cell Biol. 7:1991;375-402.
66. Brewer B. J., Fangman W. L. The localization of replication origins of ARS plasmids inS. cerevisiae. Cell. 51:1987;463-471.
67. Linskens M. H. K., Huberman J. A. Organization of replication of ribosomal DNA inSaccharomyces cerevisiae. Mol. Cell Biol. 8:1988;4927-4935.
68. Dubey D. D., Davis L. R., Greenfeder S. A., Ong L. Y., Zhu J., Broach J. R., Newlon C. S., Huberman J. A. Evidence suggesting that the ARS elements associated with silencers of the yeast mating type locus HML do not function as chromosomal replication origins. Mol. Cell. Biol. 11:1991;5346-5355.
69. Heintz N. H., Hamlin J. L. An amplified chromosomal sequence that includes the gene for dihydrofolate reductase initiates replication within a specific replication fragment. Proc. Natl. Acad. Sci. USA. 79:1982;4083-4087.
70. Burhans W. C., Selegue J. E., Heintz N. H. Isolation of the origin of replication associated with the amplified Chinese hamster dihydrofolate reductase domain. Proc. Natl. Acad. Sci. USA. 83:1986;7790-7794.
71. McWhinney C., Leffak M. Autonomous replication of a DNA fragment containing the chromosomal replication origin of the human c-myc gene. Nucleic Acids Res. 18:1990;1233-1242.
72. Iguchi-Ariga S. M. M., Okazaki T., Itani T., Ogata M., Sato Y., Ariga H. An initiation site of DNA replication with transcriptional enhancer activity present upstream of the c-myc gene. EMBO J. 7:1988;3135-3142.
73. Leffak M., James C. D. Opposite replication polarity of the germ line c-myc gene in HeLa cells compared with that of two Burkitt lymphoma cell lines. Mol. Cell. Biol. 9:1989;586-593.
74. Ariizumi K., Wang Z., Tucker P. W. Immunoglobulin heavy chain enhancer is located near or in an initiation zone of chromosomal DNA replication. Proc. Natl. Acad. Sci. USA. 90:1993;3695-3699.
75. Gale J. M., Tobey R. A., D'Anna J. A. Localization and DNA sequence of a replication origin in the rhodopsin gene locus of Chinese hamster cells. J. Mol. Biol. 224:1992;343-358.
76. James C. D., Leffak M. Polarity of DNA replication through the avian alpha globin locus. Mol. Cell. Biol. 6:1986;976-984.
77. Trempe J., Lindstrom Y. I., Leffak M. Opposite replication polarities of transcribed and nontranscribed histone H5 genes. Mol. Cell. Biol. 8:1988;1657-1663.
78. Carroll S. M., DeRose M. L., Kolman J. L., Nonet G. H., Kelly R. E., Wahl G. M. Localization of a bidirectional DNA replication origin in the native locus and in episomally amplified murine adenosine deaminase loci. Mol. Cell. Biol. 13:1993;2971-2981.
79. Handeli S., Klar A., Meuth M., Cedar H. Mapping replication units in animal cells. Cell. 57:1989;909-920.
80. Zhao Y., Tsutsumi R., Yamaki M., Nagatsuka Y., Ejiri S., Tsutsumi K. Initiation zone of DNA replication at the aldolase B locus encompasses transcription promoter region. Nucleic Acids Res. 22:1994;5385-5390.
81. Kitsberg D., Selig S., Keshet I., Cedar H. Replication structure of the human beta globin gene domain. Nature. 366:1993;588-590.
82. Kelly R. E., DeRose M. L., Draper B. W., Wahl G. M. Identification of an origin of bidirectional DNA replication in the ubiquitously expressed mammalian CAD gene. Mol. Cell. Biol. 15:1995;4136-4148.
83. Pelletier R., Mah D., Landry S., Matheos D., Price G. B., Zannis-Hadjopoulos M. Deletion analysis of ors12, a centromeric, early activated, mammalian origin of DNA replication. J. Cell. Biochem. 66:1997;87-97.
84. Giacca M., Zentilin L., Norio P., Diviacco S., Dimitrova D., Contreas G., Biamonti G., Perini G., Weighardt F., Rive S., Falaschi A. Fine mapping of a replication origin of human DNA. Proc. Natl. Acad. Sci. USA. 91:1994;7119-7123.
85. Yoon Y., Sanchez J. A., Brun C., Huberman J. A. Mapping of replication initiation sites in human ribosomal DNA by nascent-strand abundance analysis. Mol. Cell. Biol. 15:1995;2482-2489.
86. Little R. D., Platt T. H. K., Schildkraut C. L. Initiation and termination of DNA replication in human ribosomal RNA genes. Mol. Cell. Biol. 13:1994;6600-6613.
87. Leu T.-H., Hamlin J. L. High-resolution mapping of replication fork movement through the amplified dihydrofolate reductase domain in CHO cells by in-gel renaturation analysis. Mol. Cell. Biol. 9:1989;523-531.
88. Anachkova B., Hamlin J. L. Replication in the amplified dihydrofolate reductase domain in CHO cells may initiate at two distinct sites, one of which is a repetitive sequence element. Mol. Cell. Biol. 9:1989;532-540.
89. Vassilev L. T., Burhans W. C., DePamphilis M. L. Mapping an origin of DNA replication at a single-copy locus in exponentially proliferating mammalian cells. Mol. Cell. Biol. 10:1990;4685-4689.
90. Burhans W. C., Vassilev L. T., Caddle M. S., Heintz N. H., DePamphilis M. L. Identification of an origin of bidirectional DNA replication in mammalian chromosomes. Cell. 62:1990;955-965.
91. Caddle M. S., Lussier R. H., Heintz N. H. Intramolecular DNA triplexes, bent DNA and DNA unwinding elements in the initiation region of an amplified dihydrofolate reductase replicon. J. Mol. Biol. 211:1990;19-33.
92. Bianchi A., Wells R. D., Heintz N. H., Caddle M. S. Sequences near the origin of replication of the DHFR locus of Chinese hamster ovary cells adopts left-handed Z-DNA and triplex structures. J. Biol. Chem. 265:1990;21789-21796.
93. Bergemann A. D., Johnson E. M. The HeLa PUR factor binds single-stranded DNA at a specific element conserved in gene flanking regions and origins of DNA replication. Mol. Cell. Biol. 12:1992;1257-1265.
94. Caddle M. S., Dailey L., Heintz N. H. RIP60, a mammalian origin-binding protein, enhances DNA bending near the dihydrofolate reductase origin of replication. Mol. Cell. Biol. 10:1990;6236-6243.
95. Bell S. P., Stillman B. ATP-dependent recognition of eukaryotic origins of DNA replication by a multiprotein complex. Nature. 357:1992;128-134.
96. Ritzi M., Baack M., Musahl C., Romanowski P., Laskey R. A. Human minichromosome maintenance proteins and human origin recognition complex 2 protein on chromatin. J. Biol. Chem. 273:1998;24543-24549.
97. Klemm R D., Austin R. J., Bell S. P. Coordinate binding of ATP and origin DNA regulates the ATPase activity of the origin recognition complex. Cell. 88:1997;493-502.
98. Gavin K. A., Hidaka M., Stillman B. Conserved initiator proteins in eukaryotes. Science. 270:1995;1667-1671.
99. Ehrenhofer-Murray A. E., Gossen M., Pak D. T. S., Botchan M. R., Rine J. Separation of origin recognition complex functions by cross-species complementation. Science. 270:1995;1671-1675.
100. Fox C. A., Ehrenhofer-Murray A. E., Loo S., Rine J. The origin recognition complex, SIR1, and the S phase requirement for silencing. Science. 276:1997;1547-1551.
101. Blow J. J., Laskey R. A. A role for the nuclear envelope in controlling DNA replication within the cell cycle. Nature. 332:1988;546-548.
102. 21Xenopus. Cell. 69:1992;151-158.
103. Leno G. H., Laskey R. A. The nuclear membrane determines the timing of DNA replication inXenopus. J. Cell Biol. 112:1991;557-566.
104. Kearsey S. E., Labib K. MCM proteins: Evolution, properties, and role in DNA replication. Biochim. Biophys. Acta. 1398:1998;113-136.
105. Aparicio O. M., Weinstein D. M., Bell S. P. Components and dynamics of DNA replication complexes in S. cerevisiae: Redistribution of MCM proteins and Cdc45p during S phase. Cell. 91:1997;59-69.
106. Hendrickson M, Madine M., Dalton S., Gauther J. Phosphorylation of MCM4 by cdc2 protein kinase inhibits the activity of the minichromosome maintenence complex. Proc. Natl. Assoc. Sci. USA. 93:1996;12223-12228.
107. Hill A. L., Phelan S. A., Loeken M. R. Reduced expression of pax-3 is associated with overexpression of cdc46 in the mouse embryo. Dev. Genes Evol. 208:1998;128-134.
108. Sible J. C., Erikson E., Hendrickson M., Maller J. L., Gautier J. Developmental regulation of MCM replication factors inXenopus laevis. Curr. Biol. 8:1998;347-350.
109. DePamphilis M. L. How transcription factors regulate origins of DNA replication in eukaryotic cells. Trends Cell Biol. 3:1993;161-167.
110. Lin S., Kowalski D. Functional equivalency and diversity of cis-acting elements among yeast replication origins. Mol. Cell. Biol. 17:1997;5473-5484.
111. Li R., Yu D. S., Tanaka M., Zheng L., Berger S. L., Stillman B. Activation of chromosomal DNA replication inSaccharomyces cerevisiae. Mol. Cell. Biol. 18:1998;1296-1302.
112. O'Neill E. A., Kelly T. J. Purification and characterization of nuclear factor III (origin recognition protein C), a sequence-specific DNA binding protein required for efficient initiation of adenovirus DNA replication. J. Biol. Chem. 263:1988;931-937.
113. Lakin N. D., Palmer R., Lillycrop K. A., Howard M. K., Burke L. C., Thomas N. S., Latchman D. S. Down regulation of the octamer binding protein Oct-1 during growth arrest and differentiation of a neuronal cell line. Brain Res. 28:1995;47-54.
114. Reeves F. C., Fredericks W. J., Rauscher F. J. 3rd, Lillycrop K. A. The DNA binding actiity of the paired box transcription factor Pax-3 is rapidly downregulated during neuronal cell differentiation. FEBS Lett. 422:1998;118-122.
115. Matheos D. D., Ruiz M. T., Price G. B., Zannis-Hadjopoulos M. Oct-1 enhances thein vitro. J. Cell. Biochem. 68:1998;309-327.
116. van Leeuwen H. C., Rensen M., van der Vliet P. C. The Oct-1 POU homeodomain stabilizes the adenovirus preinitiation complex via a direct interaction with the priming protein and is displaced when the replication fork passes. J. Biol. Chem. 272:1997;3398-3405.
117. 3. J. Cell. Physiol. 128:1986;171-179.
118. Foiani M., Lucchini G., Plevani P. The DNA polymerase α-primase complex couples DNA replication, cell-cycle progression and DNA-damage response. Trends Biochem. Sci. 22:1997;424-427.
119. Feng J. A., Crasto C. J., Matsumoto Y. Deoxyribose phosphate excision by the N-terminal domain of the polymerase beta: The mechanism revisited. Biochemistry. 37:1998;9605-9611.
120. Longley M. J., Ropp P. A., Lim S. E., Copeland W. C. Characterization of the native and recombinant catalytic subunit of human DNA polymerase γ: Identification of residues critical for exonuclease activity and dideoxynucleotide sensitivity. Biochemistry. 37:1998;10529-10539.
121. Wood R. D., Shivji M. K. Which DNA polymerases are used for DNA-repair in eukaryotes? Carcinogenesis. 18:1997;605-610.
122. Lawrence C. W., Hinkle D. C. DNA polymerase ζ and the control of DNA damage induced mutagenesis in eukaryotes. Cancer Surv. 28:1996;21-31.
123. Kelman Z., O'Donnell M. Structural and functional similarities of prokaryotic and eukaryotic DNA polymerase sliding clamps. Nucleic Acids Res. 23:1995;3613-3620.
124. Bravo R., Frank R., Blundell P. A., MacDonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase δ Nature. 326:1987;515-517.
125. Prelich G., Tan C.-K., Kostura M., Mathews M. B., So A. G., Downey K. M., Stillman B. Functional identity of proliferating cell nuclear antigen and a DNA-polymerase delta auxiliary protein. Nature. 326:1987;517-520.
126. Hindges R., Hubscher U. DNA polymerase δ, an essential enzyme for DNA transactions. Biol. Chem. 378:1997;345-362.
127. Jonsson Z. O., Hubscher U. Proliferating cell nuclear antigen: More than a clamp for DNA polymerases. BioEssays. 19:1997;967-975.
128. Malkas L. H., Hickey R. J., Li C.-J., Pederson N., Baril E. F. A 21S enzyme complex from HeLa cells that functions in simian virus 40 DNA replicationin vitro. Biochemistry. 29:1990;6362-6374.
129. Coll J. M., Sekowski J. G. W., Hickey R. J., Schnaper L., Wei Y., Brodie A., Syvaoja J., Malkas L. H. The human breast cell DNA synthesome: Its purification, from tumor tissue and cell culture. Oncol. Res. 8:1996;435-447.
130. Lin S., Hickey R., Malkas L. The biochemical status of the DNA synthesome can distinguish between permanent and temporary cell growth arrest. Cell Growth Differ. 8:1997;1359-1369.
131. Slijepcevic P. Telomere length regulation - A view from the individual chromosome perspective. Exp. Cell Res. 244:1998;268-274.
132. Shore D. Telomeres - Unsticky ends. Science. 281:1998;1818-1819.
133. Greider C. W. Telomerase activity, cell proliferation, and cancer. Proc. Natl. Acad. Sci. USA. 95:1998;90-92.
134. Stewart E., Enoch T. S-phase and DNA-damage checkpoints: A tale of two yeasts. Curr. Opin. Cell Biol. 8:1996;781-787.
135. Ogoshi M., Takashima A., Taylor R. S. Mechanisms regulating telomerase activity in murine T cells. J. Immunol. 158:1997;622-628.
136. Broccoli D, Young J. W., DeLange T. Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. USA. 92:1995;9082-9086.
137. Hiyama K., Hirai Y., Kyoizumi S., Akiyama M., Hiyama E., Piatyszek M. A., Shay J. W., Ishioka S., Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155:1995;3711-3715.
138. Weng N.-P., Levine B. L., June C. H., Hodes R. J. Regulated expression of telomerase activity in human T lymphocyte development and activation. J. Exp. Med. 183:1996;2471-2479.
139. Vaziri H., Dragowska W., Allsopp R. C., Thomas T. E., Harley C. B., Lansdorp P. M. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA. 91:1994;9857-9860.
140. Carman T. A., Afshari C. A., Barrett J. C. Cellular senescence in telomerase-expressing Syrian hamster embryo cells. Exp. Cell Res. 244:1998;33-42.
141. DeLange T. Activation of telomerase in a human tumor. Proc. Natl. Acad. Sci. USA. 91:1994;2882-2885.
142. Shay J. W., Werbin H., Wright W. E. Telomeres and telomerase in human leukemias. Leukemia. 10:1996;1255-1261.
143. Morales C. P., Lee E. L., Shay J. W. In situ. Cancer. 83:1998;652-659.
144. Sharma H. W., Sokoloski J. A., Perez J. R., Maltese J. Y., Sartorelli A. C., Stein C. A., Nichols G., Khaled Z., Telang N. T., Narayanan R. Differentiation of immortal cells inhibits telomerase activity. Proc. Natl. Acad. Sci. USA. 92:1995;12343-12346.
145. Zhu X., Kumar R., Mandal M., Sharma N., Sharma H. W., Dhingra U., Sokoloski J. K., Hsiao R., Narayanan R. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc. Natl. Acad. Sci. USA. 93:1996;6091-6095.
146. Reichman T. W., Albanell J., Wang X., Moore M. A. S., Studzinski G. P. Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein. J. Cell. Biochem. 67:1997;13-23.
147. Cook P. R. The nucleoskeleton and the topology of replication. Cell. 66:1991;627-635.
148. Hozak P., Hassan A. B., Jackson D. A., Cook P. R. Visualization of replication factories attached to a nucleoskeleton. Cell. 73:1993;361-373.
149. Jackson D. A., Cook P. R. The structural basis of nuclear function. Int. Rev. Cytol. 162A:1995;125-149.
150. Berezney R., Mortillaro M. J., Ma H., Wei X., Samarabandu J. The nuclear matrix: A structural milieu for genomic function. Int. Rev. Cytol. 162A:1995;1-65.
151. Wei X., Samarabandu J., Devdhar R. S., Siegal A. J., Acharya R., Berezney R. Segregation of transcription and replication sites into higher order domains. Science. 281:1998;1502-1505.
152. Lemon K. P., Grossman A. D. Localization of bacterial DNA polymerase: Evidence for a factory model of replication. Science. 282:1998;1516-1519.
153. Nakayasu H., Berezney R. Mapping replication sites in the eukaryotic cell nucleus. J. Cell Biol. 108:1989;1-11.
154. Stein G. S., vanWijnen A. J., Stein J. L., Lian J. B., Pockwinse S., McNeil S. Interrelationships of nuclear structure and transcriptional control: Functional consequences of being in the right place at the right time. J. Cell. Biochem. 70:1998;200-212.
155. Linares-Cruz G., Bruzzoni-Giovanelli H., Alvaro V., Roperch J. P., Tuynder M., Schoevaert D., Nemani M., Prieur S., Lethrosne F., Piouffre L., Reclar V., Faille A., Chassoux D., Dausset J., Amson R. B., Calvo F., Telerman A. p21/WAF-1 reorganizes the nucleus in tumor suppression. Proc. Natl. Acad. Sci. USA. 95:1998;1131-1135.
156. Fey E. G., Penman S. Nuclear matrix proteins reflect cell type of origin in cultured cells. Proc. Natl. Acad. Sci. USA. 85:1988;121-125.
157. Dworetzky S. I., Fey E. G., Penman S., Lian J. B., Stein J. L., Stein G. S. Progressive changes in the protein composition of the nuclear matrix during rat osteoblast differentiation. Proc. Natl. Acad. Sci. USA. 87:1990;4605-4609.
158. Guo B., Odgren P. R., van Wijnen A. J., T. J., Nickerson J., Penman S., Lian J. B., Stein J. L., Stein G. S. The nuclear matrix protein NMP-1 is the transcription factor YY1. Proc. Natl. Acad. Sci. USA. 92:1995;10526-10530.
159. Bates S., Ryan K. M., Phillips A. C., Vousden K. H. Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1. Oncogene. 17:1998;1691-1703.
160. MacAuley A., Cross J. C., Werb Z. Reprogramming the cell cycle for endoreduplication in rodent trophoblast cells. Mol. Biol. Cell. 9:1998;795-807.
161. Matsumura I., Ishikawa J., Nakajima K., Oritani K., Tomiyama Y., Miyagawa J., Kato T., Miyazaki H., Matsuzawa Y., Kanakura Y. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21 (WAF1/Cip1) by STAT5. Mol. Cell. Biol. 17:1997;2933-2943.
162. Kikuchi J., Furukawa Y., Iwase S., Terui Y., Nakamura M., Kitagawa S., Kitagawa M., Komatsu N., Miura Y. Polyploidization and functional maturation are two distinct processes during megakaryocytic differentiation: involvement of cyclin-dependent kinase inhibitor p21 in polyploidization. Blood. 89:1997;3980-3990.
163. Datta N. S., Williams J., Caldwell J., Curry A. M., Ashcroft E. K., Long M. W. Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content. Mol. Biol. Cell. 7:1996;209-223.
164. 32.
165. 3. Cancer Res. 56:1996;5513-5521.
166. 12. Mol. Cell. Biol. 18:1998;629-643.